Ground breaking study published in Journal of Biophotonics

Ground breaking study published in Journal of Biophotonics

A study concerning a new possibility to develop a light-based surveillance modality for prematurely born infants has been published in the Journal of Biophotonics. The paper “Comparison of dermal versus internal light administration in human lungs using the...

About GPX Medical

GPX Medical AB was formed in 2016 as a subsidiary to GASPOROX AB (publ), with the aim to develop and commercialize medical applications of GASMAS technology. The company is owned to 60% by GASPOROX AB (publ) and to 40% by Norsk Elektro Optikk AS, and located in Lund, Sweden. Org. nbr. 559069-9012.

For investors

Please contact CEO Hanna Sjöström for investment opportunities:
hs@gpxmedical.se

Contact

GPX Medical AB
Maskinvägen 1
223 70 Lund
Sweden
info@gpxmedical.se